Yanli Ji

Zhengzhou, 450001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

RNA Sequencing and Targeted Knockdown Reveal miR-142a-5p as a Driver of Retinal Degeneration in rd1 Mice.

RNA Sequencing and Targeted Knockdown Reveal miR-142a-5p as a Driver of Retinal Degeneration in rd1 Mice.

Journal: Biology

Published: September 04, 2025

Ultrasensitive Digital Immunoassay in Homogenous Format by Singlet-Oxygen Activated Up-conversion Luminescence.

Ultrasensitive Digital Immunoassay in Homogenous Format by Singlet-Oxygen Activated Up-conversion Luminescence.

Journal: Angewandte Chemie (International ed. in English)

Published: May 14, 2025

Decitabine improves MMS-induced retinal photoreceptor cell damage by targeting DNMT3A and DNMT3B.

Decitabine improves MMS-induced retinal photoreceptor cell damage by targeting DNMT3A and DNMT3B.

Journal: Frontiers in molecular neuroscience

Published: September 29, 2022

Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.

Raloxifene, identified as a novel LSD1 inhibitor, suppresses the migration of renal cell carcinoma.

Journal: Future medicinal chemistry

Published: February 02, 2021

LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p.

LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p.

Journal: Cancer cell international

Published: May 13, 2019

Secretogranin III as a novel target for the therapy of choroidal neovascularization.

Secretogranin III as a novel target for the therapy of choroidal neovascularization.

Journal: Experimental eye research

Published: May 15, 2018

Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.

Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.

Journal: Angiogenesis

Published: November 27, 2016

Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy.

Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy.

Journal: The Journal of experimental medicine

Published: October 25, 2016

The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.

The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.

Journal: Molecular vision

Published: August 29, 2015

Showing 1-9 of 9

Last Updated: 09/26/2026